Buy Semaglutide 5mg: GLP-1 Receptor Agonist for Metabolic & Diabetes Research

Semaglutide (5mg) is a synthetic long-acting GLP-1 receptor agonist widely researched for its powerful effects on type 2 diabetes and obesity. Clinical trial programs such as SUSTAIN (diabetes) and STEP (weight management) demonstrate its ability to enhance insulin sensitivity, suppress appetite, achieve meaningful weight loss, and deliver potential cardiovascular risk reduction. This high-purity research-grade peptide, supplied in a 5mg vial with 99% purity, is ideal for studying incretin biology, dose titration protocols, glycemic control, satiety mechanisms, lipolysis, and metabolic regulation in experimental models.

Molecular Formula: C187H291N45O59 Molecular Weight: 4113.6–4114 g/mol Purity: 99%

Important Notice: This peptide is strictly intended for research and laboratory use only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes. Please review and agree to our Terms and Conditions before placing an order.

What is Semaglutide?

Semaglutide is a structurally optimized analog of native GLP-1, featuring three key modifications:

• Aib (2-aminoisobutyric acid) at position 8 for DPP-4 resistance
• Arginine substitution at position 34
• A C18 fatty diacid chain attached via a γ-glutamic acid and two 8-amino-3,6-dioxaoctanoic acid (OEG) spacers at Lys26

These changes provide strong albumin binding and enzymatic stability, resulting in a ~1-week half-life suitable for once-weekly administration analogs in research.

The 5mg vial is particularly useful for initiation-phase simulations, low-to-moderate dose studies, titration protocol modeling, pharmacokinetics, or experiments requiring smaller cumulative quantities.

Mechanism of Action.

Semaglutide activates GLP-1 receptors to:

• Stimulate glucose-dependent insulin secretion from pancreatic beta cells
• Suppress glucagon release when glucose is elevated
• Slow gastric emptying and promote early satiety
• Reduce central appetite drive and food intake
• Improve peripheral insulin sensitivity and beta-cell function

This coordinated incretin action lowers both fasting and postprandial glucose while preferentially reducing visceral adipose tissue.

Cardiovascular & Cardiometabolic Effects

Research indicates favorable changes in systolic blood pressure, lipid profiles (reduced triglycerides and LDL), inflammatory markers, and potential reduction in major adverse cardiovascular events in high-risk populations.

Research Applications

The 5mg vial supports:

• Type 2 diabetes pathway, beta-cell function, and adjunct therapy studies
• Obesity models, appetite regulation, and energy intake experiments
• Dose-escalation / titration simulations and early-phase exposure studies
• Incretin biology, gastric motility, satiety signaling, and metabolic syndrome research

Reconstitution example (lab protocols vary): Dissolve in bacteriostatic water to create concentrations suitable for low-to-moderate weekly dosing analogs.

Why Choose 99% Pure Semaglutide 5mg?

Our semaglutide 5mg delivers ≥99% purity for consistent, reproducible results in receptor activation, insulin dynamics, appetite assays, and long-term metabolic endpoint measurements. Vacuum-sealed and third-party tested to ensure experimental reliability.

In summary, Semaglutide 5mg is a premium GLP-1 receptor agonist for advanced research into type 2 diabetes management, weight loss mechanisms, appetite suppression, insulin sensitivity, and cardiometabolic health. Advance your incretin and metabolic studies with this high-quality research peptide.

Latest Testing: Link to Report